Concerns and Outlook on China Neuro-Interventional Industry
The insight analyzed China neuro-interventional industry including the reason of cool-down in primary market, the product homogenization, fierce...
507 Views
Lifetech Scientific (1302.HK) - A “dark Horse” in China Innovative Device Industry
This insight analyzed Lifetech in terms of its three main product lines, the growth points and the outlook in the future, short-term catalysts and...
397 Views
China Healthcare Weekly (Nov.12)-Medical Insurance Negotiation,Spring Coil VBP,Valuation Upside Down
This insight mainly analyzed some news circulating about 2021 national medical insurance negotiation results, VBP on spring coil in Hebei and...
143 Views
MicroPort MedBot Pre-IPO - Valuation Appears Reasonable but Sentiment Will Weigh
Shanghai MicroPort MedBot Group (MM), a surgical robot company, aims to raise up to US$200m in its Hong Kong IPO. Valuation appears reasonable but...
325 Views
China Healthcare Weekly (Sep.24) - VBP on Neuro-Intervention, Payment System Changes, AI in Drug R&D
This article analyzed the centralized procurement on spring coil in Hebei province, commercial insurance coverage for dental items, AI in new drug...
237 Views